Research reveals link between immunity, diabetes

September 14, 2018 by Bill Snyder, Vanderbilt University
Credit: CC0 Public Domain

When it comes to diet-induced obesity, your immune system is not always your friend.

Adipose (fatty) tissue is infiltrated by that have been linked to the development of inflammation, and type 2 diabetes. How this happens is complicated and under intense investigation by researchers around the world.

Now, from a study in mice fed a high-fat diet, Vanderbilt researchers report that a type of immune cell called the CD8+ T cell is activated in fatty tissue by isolevuglandins (isoLGs), chemical products of fatty acid oxidation.

Part of the body's immune defense system, CD8+ cells attack bacteria, viruses and unhealthy cells including . But in fat they also contribute to inflammation, which is thought to block insulin's ability to remove glucose from the blood. Insulin "resistance," in turn, can lead to type 2 diabetes.

"This study is important because it enhances our understanding of the immune system and how it contributes to insulin resistance in the setting of obesity," said the paper's first author, Wyatt McDonnell, a graduate student in the Department of Pathology, Microbiology and Immunology at Vanderbilt University School of Medicine.

The findings, reported last week in the journal Diabetes, suggest that drugs could be developed to prevent or reverse insulin resistance by targeting isoLGs or CD8+ cells in fatty tissue, added the paper's corresponding author, Arion Kennedy, Ph.D., a former Vanderbilt faculty member now at North Carolina State University in Raleigh.

The current study was made possible by Kennedy, co-author Alyssa Hasty, Ph.D., and colleagues who showed in earlier work that CD8+ cells can be isolated from adipose tissue. Hasty is the Cornelius Vanderbilt Chair and professor in the Department of Molecular Physiology and Biophysics.

CD8+ T cells contain unique and highly variable "barcodes" that enable them to recognize their targets. Using sophisticated cell sorting and gene-sequencing technology provided through the Vanderbilt Flow Cytometry Shared Resource and VANTAGE (Vanderbilt Technologies for Advanced Genomics), the researchers sequenced the barcode of each CD8+ cell isolated from fat.

This part of the research and the computational analysis was led by McDonnell, who worked with co-author and VANTAGE Scientific Director Simon Mallal, MBBS, the Major E.B. Stahlman Professor of Infectious Diseases and Inflammation.

The researchers found that the barcode changed under conditions of diet-induced obesity. "This led us to discover that isoLGs—a type of modified protein made by cells experiencing stress and injury from oxygen free radicals—are elevated in the fat," McDonnell said, and that CD8+ cells are activated by them.

"This study is the first to show that the accumulation of CD8+ cells in fat during obesity is not a random process," said co-author John Koethe, MD, MSCI, assistant professor of Medicine at Vanderbilt.

Koethe said the findings are relevant for patients with HIV disease who also have elevated levels of CD8+ cells in fat and are at high risk of developing diabetes. Last year he received a five-year, $3.6 million grant from the National Institutes of Health (NIH) to better understand and find a solution to this problem.

Studies conducted by co-author Annet Kirabo, Ph.D., MSc, assistant professor in the Division of Clinical Pharmacology, and colleagues also have linked IsoLGs to the development of high blood pressure and vascular disease.

This suggests a conserved pathway by which the immune system "misbehaves" in hypertension, diabetes and obesity. "It also means we could potentially intervene in these settings by quieting down the immune system or by lowering the on cells in the fat," McDonnell said.

Explore further: Gamma-Delta T cells may play a role in insulin resistance and type 2 diabetes

More information: Wyatt J. McDonnell et al. High CD8 T Cell Receptor Clonality and Altered CDR3 Properties are Associated with Elevated Isolevuglandins in Adipose Tissue During Diet-Induced Obesity, Diabetes (2018). DOI: 10.2337/db18-0040

Related Stories

Gamma-Delta T cells may play a role in insulin resistance and type 2 diabetes

January 5, 2015
New research in mice suggests that an unusual type of immune cell called "γδ T cells" may be a new drug and research target for treating or preventing type 2 diabetes caused by obesity. The research report, appearing in ...

Natural killer cells help to drive inflammation and insulin resistance

March 31, 2016
In obesity, the body's immune system can treat tissues as if they are suffering from a low-grade chronic infection. This obesity-induced inflammation is an important contributor to insulin resistance, a condition that can ...

Accelerated immune aging may contribute to obesity-linked metabolic disease

November 7, 2016
Obese individuals are at an elevated risk of developing comorbid cardiovascular and metabolic diseases, such as type 2 diabetes. Some research suggests that these comorbid diseases develop in response to chronic inflammation ...

Immune system killer cells increase risk of diabetes

July 6, 2017
More than half of the German population is obese. One effect of obesity is to chronically activate the immune system, placing it under continuous stress. Researchers in Jens Brüning's team at the Max-Planck-Institute for ...

Study reveals therapeutic targets to alter inflammation, type 2 diabetes

March 12, 2013
New research from Boston University School of Medicine (BUSM) reveals that B cells regulate obesity-associated inflammation and type 2 diabetes through two specific mechanisms. The study, published in the Proceedings of the ...

Insulin resistance reversed by removal of protein

November 3, 2016
By removing the protein galectin-3 (Gal3), a team of investigators led by University of California School of Medicine researchers were able to reverse diabetic insulin resistance and glucose intolerance in mouse models of ...

Recommended for you

New insights into how an ordinary stem cell becomes a powerful immune agent

November 19, 2018
How do individual developing cells choose and commit to their "identity"—to become, for example, an immune cell, or a muscle cell, or a neuron?

New inflammation inhibitor discovered

November 16, 2018
A multidisciplinary team of researchers led from Karolinska Institutet in Sweden have developed an anti-inflammatory drug molecule with a new mechanism of action. By inhibiting a certain protein, the researchers were able ...

Pets can double as asthma antidote

November 16, 2018
(HealthDay)—The "hygiene hypothesis" holds that early exposure to a variety of microorganisms may decrease the risk for chronic inflammatory diseases, like asthma.

New study shows NKT cell subsets play a large role in the advancement of NAFLD

November 16, 2018
Since 2015 it has been known that the gut microbiota could have a direct impact on nonalcoholic fatty liver disease (NAFLD), which affects up to 12% of adults and is a leading cause of chronic liver disease. In the November ...

Defense against intestinal infection in organism is affected by prostaglandin E2

November 15, 2018
The treatment of intestinal infections caused by some strains of the bacterium Escherichia coli, present in unsanitized or contaminated foods, may have a new ally.

No link between 'hypoallergenic' dogs and lower risk of childhood asthma

November 15, 2018
Growing up with dogs is linked to a lower risk of asthma, especially if the dogs are female, a new study from Karolinska Institutet and Uppsala University in Sweden shows. However, the researchers found no relation between ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.